Neurologist Dr. Richard Bedlack, who leads the Duke ALS Clinic, has been named director of patient advocacy and outreach for the Clinical Research in ALS and Related Disorders for Therapeutic Development Consortium, funded by a $6.24 million grant from the National Institutes of Health.
No comments:
Post a Comment